February 2024
1. NUMATA K, Shiozawa M, Ono Y, Iguchi K, et al
   Clinical significance of the post/preoperative anti-p53 antibody ratio in predicting the prognosis of patients with colorectal cancer after curative surgery and its usefulness in combination with carcinoembryonic antigen.
   Oncology. 2024 Feb 21. doi: 10.1159/000537963.
   

   >> Share

   
   January 2024
2. TOQUERO P, Mondejar R, Romero-Laorden N, Mendez E, et al
   Is older age an independent prognostic factor of survival in metastatic colorectal cancer?
   Oncology. 2024 Jan 17. doi: 10.1159/000535187.
   

   >> Share

   
   
3. MIYAGAWA Y, Kitazawa M, Tokumaru S, Nakamura S, et al
   Impact of Oophorectomy on Survival and Improving Nutritional Status in Ovarian Metastasis from Colorectal Adenocarcinoma.
   Oncology. 2024;102:114-121.
   

   >> Share

   
   
4. VIVALDI C, Genovesi V, Ugolini C, Bernardini L, et al
   Mismatch Repair Deficiency in Biliary Tract Cancer: Prognostic Implications and Correlation with Histology.
   Oncology. 2024;102:157-167.
   

   >> Share

   
   
5. JATHO A, Myung SK, Kim J, Han SS, et al
   Consumption of Sugar-Sweetened Soft Drinks and Risk of Gastrointestinal Cancer: A Systematic Review and Meta-Analysis of Observational Studies.
   Oncology. 2024;102:141-156.
   

   >> Share

   
   
6. MATSUNAKA T, Goi T, Kurebayashi H, Morikawa M, et al
   18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging-Defined Extramural Venous Invasion Predicts Distant Metastasis and Reflects Strong Tumor Invasiveness in Rectal Cancer.
   Oncology. 2024;102:99-106.
   

   >> Share

   
   December 2023
7. MIAO R, Kim DW, Yu J, Malafa M, et al
   RNA Expression-based Analysis to Predict Response in Patients with Metastatic Mismatch Repair Proficient Colorectal Cancer Treated with Regorafenib and Nivolumab.
   Oncology. 2023 Dec 7. doi: 10.1159/000535599.
   

   >> Share

   
   November 2023
8. ZHU C, Ji D, Ma J, Da M, et al
   Association between artificial sweeteners-aspartame consumption and colorectal cancer risk: evidence-based strategies.
   Oncology. 2023 Nov 2. doi: 10.1159/000534812.
   

   >> Share

   
   October 2023
9. UROOG L, Rahmani AH, Alsahli MA, Almatroodi SA, et al
   Genetic profile of FOXO3 Single Nucleotide Polymorphism in colorectal cancer patients.
   Oncology. 2023 Oct 19. doi: 10.1159/000533729.
   

   >> Share

   
   September 2023
10. PREJAC J, Omrcen T, Radic J, Vrdoljak E, et al
    Predicting Trifluridine/Tipiracil Treatment Outcomes in Refractory Metastatic Colorectal Cancer Patients: A Multicenter Exploratory Analysis.
    Oncology. 2023 Sep 12. doi: 10.1159/000533567.
    

    >> Share

    
    
11. DOLESCHAL B, Niedersuss-Beke D, Kirchweger P, Petzer A, et al
    Survival outcome in early onset metastatic colorectal cancer: a multicenter matched-pair analysis.
    Oncology. 2023 Sep 12. doi: 10.1159/000533429.
    

    >> Share

    
    June 2023
12. BARDAKCI M, Demirtas Esmer D, Hafizoglu E, Yaslikaya S, et al
    Comparison of the efficacy and safety of 3 months of CAPOX followed by 3 months of capecitabine and 6 months of CAPOX/FOLFOX in the adjuvant treatment of low-risk stage-III colon cancer treated surgically.
    Oncology. 2023 Jun 28. doi: 10.1159/000531722.
    

    >> Share

    
    
13. GIANNOPOULOU N, Constantinou C
    Recent developments in diagnostic and prognostic biomarkers for colorectal cancer: a narrative review.
    Oncology. 2023 Jun 26. doi: 10.1159/000531474.
    

    >> Share

    
    March 2023
14. MAUREL JM, Tamayo MB, Pitargue R, Ong-Cornel AB, et al
    Practical notes on the current ESMO consensus guidelines for the management of patients with metastatic colorectal cancer in resource-constrained environments of low- to middle-income countries.
    Oncology. 2023 Mar 23. doi: 10.1159/000530275.
    

    >> Share

    
    January 2023
15. SUZUKI T, Sadahiro S, Okada K, Miyakita H, et al
    Clinical T2N0 Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy plus Local Excision.
    Oncology. 2023;101:166-172.
    

    >> Share

    
    
16. DRAPER A, Jung EH, Cao Y, Atallah RP, et al
    The Impact of Poorly Differentiated Histology on Immunotherapy in Advanced Gastrointestinal Cancers.
    Oncology. 2023;101:213-223.
    

    >> Share

    
    
17. DUQUE-SANTANA V, Lopez-Campos F, Martin-Martin M, Valero M, et al
    Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors in Locally Advanced Rectal Cancer.
    Oncology. 2023;101:349-357.
    

    >> Share

    
    October 2022
18. OKAMOTO K, Nozawa H, Emoto S, Murono K, et al
    Adjuvant Capecitabine and Oxaliplatin for Elderly Patients with Colorectal Cancer.
    Oncology. 2022 Oct 17:1-7. doi: 10.1159/000527012.
    

    >> Share

    
    
19. KIM TW, Hwang SW, Kim KO, Cha JM, et al
    The prognostic utilities of DNA mismatch repair status and KRAS and BRAF mutation in Korean colorectal cancer patients: The KASID multicenter study.
    Oncology. 2022 Oct 3. pii: 000527285. doi: 10.1159/000527285.
    

    >> Share

    
    September 2022
20. SAWAI K, Goi T, Sakamoto S, Matsunaka T, et al
    Oxidative stress as a biomarker for predicting the prognosis of patients with colorectal cancer.
    Oncology. 2022 Sep 16. pii: 000527032. doi: 10.1159/000527032.
    

    >> Share

    
    July 2022
21. HUANG CY, Pai YC, Yu LC
    Glucose conferred irinotecan chemoresistance through divergent actions of pyruvate and ATP in cell death and proliferation of colorectal cancer.
    Oncology. 2022 Jul 18. pii: 000525977. doi: 10.1159/000525977.
    

    >> Share

    
    January 2022
22. TAIRA T, Nozawa H, Kawai K, Sasaki K, et al
    Prognoses in Pathologically Confirmed T1 Lower Rectal Cancer Patients with or without Preoperative Therapy: An Analysis Using the Surveillance, Epidemiology, and End Results Database.
    Oncology. 2022;100:82-88.
    

    >> Share

    
    
23. SETO S, Tsujikawa T, Sawai K, Kurebayashi H, et al
    Feasibility of [18F]FDG PET/MRI with Early-Delayed and Extended PET as One-Stop Imaging for Staging and Predicting Metastasis in Rectal Cancer.
    Oncology. 2022;100:212-220.
    

    >> Share

    
    November 2021
24. BJORKMAN K, Kaprio T, Beilmann-Lehtonen I, Stenman UH, et al
    TATI, TAT-2, and CRP as Prognostic Factors in Colorectal Cancer.
    Oncology. 2021 Nov 18:1-9. doi: 10.1159/000518956.
    

    >> Share

    
    October 2021
25. WEIN A, Stoehr R, Kersting S, Siebler J, et al
    A Possible Distinct Molecular Subtype (Quintuple-Wildtype) of Metastatic Colorectal Cancer in First-Line Anti-EGFR Therapy with Cetuximab Plus FOLFIRI - Palliative Precision Therapy and a Multidisciplinary Treatment Approach: Interim Analysis of the I
    Oncology. 2021 Oct 20:1-11. doi: 10.1159/000519252.
    

    >> Share

    
    January 2021
26. REIJONEN P, Peltonen R, Tervahartiala T, Sorsa T, et al
    Serum Matrix Metalloproteinase-8 and Myeloperoxidase Predict Survival after Resection of Colorectal Liver Metastases.
    Oncology. 2021;99:766-779.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share